NASDAQ
7.39USD
+0.59 (+8.68%)
We have scored 3 news catalysts on Alpha Teknova, Inc. (TKNO) over the past 12 months. The biggest single-day move next to one of them came Oct 21, 2026, when TKNO closed +8.7%: “Teknova Announces Pricing of $40 Million Public Offering of Common Stock”. Coverage across the window leans positive (average ticker sentiment +0.27). Most of the impact sits in price momentum and eps growth rate.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
396.8M
P/E
—
EPS
—
Beta
0.73
52W range
1.91-9.48
Day range
6.81–7.67
Open
6.81
Prev close
6.80
Volume
430.2K
Avg volume
236.6K
Dividend
0.00
IPO
2021-06-25
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Alpha Teknova, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for TKNO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
